SynThera Biomedical aims to become India’s first and foremost company to indigenously research, develop, manufacture and commercialize bioactive and other specialty glass and ceramic products for healthcare and other sectors. With a product development focus that encompasses standard compositions and custom-made/proprietary formulations, we are completely committed to satisfying the needs of our customers for newer and improved materials that combine exceptional quality with highly competitive prices.

Our newly launched product development facility is located at NCL Innovation Park on the campus of National Chemical Laboratories, India’s top R&D institution for the chemical and material sciences. Our location in Pune and proximity to Mumbai place us at the heart of one of India’s largest manufacturing, research and commercial hubs for the specialty materials industry.

With over 15 years of combined R&D experience in glass and ceramic biomaterials, we bring a relentlessly research-driven approach to our work as glass and ceramic technologists, and we are firmly rooted in our objective to provide customers with products that incorporate our QAI philosophy (Quality-Affordability-Innovation) and stay true to the values that led to our name (SYNergy + THERApy = SynThera)

We are passionate about glass and ceramic materials and we bring the same passion to understanding our customer's needs and providing solutions to their material problems, whether through our own product development or through contract research projects. If you would like to know more about how we can work with you, please do not hesitate to contact us.

Latest News

Post 3_3

Indian Theranostics Scene

India is yet to get its share of modern Theranostics field. There are a few start-up companies in India that […]

Post 2_1

Road Map to 2025

While the Indian Biotechnology sector is stalled at $4 billion for the last few years, the strategy aims to achieve a […]

post 1_1

Hot Start­up: Thinking longevity over valuation

Dr Nilay Lakhkar (30) returned to India in December 2014 after completing his eight-month post-doctoral stint at Helmholtz Institute of […]

See all our news